Neurogene Balance Sheet Health
Financial Health criteria checks 6/6
Neurogene has a total shareholder equity of $155.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $179.8M and $24.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$153.91m |
| Equity | US$155.01m |
| Total liabilities | US$24.81m |
| Total assets | US$179.82m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: NGNE's short term assets ($159.1M) exceed its short term liabilities ($13.1M).
Long Term Liabilities: NGNE's short term assets ($159.1M) exceed its long term liabilities ($11.7M).
Debt to Equity History and Analysis
Debt Level: NGNE is debt free.
Reducing Debt: NGNE had no debt 5 years ago.
Debt Coverage: NGNE has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: NGNE has no debt, therefore coverage of interest payments is not a concern.